U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 770

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:7571520-7571521
GRCh38:
Chr17:7668202-7668203
TP53Li-Fraumeni syndromePathogenic
(May 18, 2017)
criteria provided, single submitter
2.
GRCh37:
Chr17:7571720-7573008
GRCh38:
Chr17:7668402-7669690
TP53Li-Fraumeni syndromeLikely pathogenic
(Jun 4, 2016)
criteria provided, single submitter
3.
GRCh37:
Chr17:7572906-7579931
GRCh38:
Chr17:7669588-7676613
TP53M1fsB-cell chronic lymphocytic leukemiaPathogenic
(Mar 19, 2021)
no assertion criteria provided
4.
GRCh37:
Chr17:7572917-7579922
GRCh38:
Chr17:7669599-7676604
TP53Li-Fraumeni syndromePathogenic
(Jan 14, 2019)
criteria provided, single submitter
5.
GRCh37:
Chr17:7572921-7579918
GRCh38:
Chr17:7669603-7676600
TP53Li-Fraumeni syndromePathogenic
(Aug 14, 2017)
criteria provided, single submitter
6.
GRCh37:
Chr17:7572921-7574039
GRCh38:
Chr17:7669603-7670721
TP53Li-Fraumeni syndromeLikely pathogenic
(Feb 15, 2017)
criteria provided, single submitter
7.
GRCh37:
Chr17:7572984
GRCh38:
Chr17:7669666
TP53Q243fs, Q216fs, Q375fs, Q336fsnot providedPathogenic
(Mar 23, 2015)
criteria provided, single submitter
8.
GRCh37:
Chr17:7573009
GRCh38:
Chr17:7669691
TP53Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Jul 10, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr17:7573010
GRCh38:
Chr17:7669692
TP53Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1,
Li-Fraumeni syndrome
Pathogenic/Likely pathogenic
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr17:7573925
GRCh38:
Chr17:7670607
TP53Li-Fraumeni syndromeLikely pathogenic
(Jan 18, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr17:7573944
GRCh38:
Chr17:7670626
TP53S323fs, S362fs, S230fs, S203fsBone marrow failure syndrome 5Pathogenic
(Jan 25, 2023)
criteria provided, single submitter
12.
GRCh37:
Chr17:7573950
GRCh38:
Chr17:7670632
TP53S323fs, S362fs, S203fs, S230fsBone marrow failure syndrome 5Pathogeniccriteria provided, single submitter
13.
GRCh37:
Chr17:7573967
GRCh38:
Chr17:7670649
TP53Q354*, Q222*, Q315*, Q195*Li-Fraumeni syndromeLikely pathogenic
(Aug 9, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr17:7573972-7573981
GRCh38:
Chr17:7670654-7670663
TP53E190fs, E217fs, E310fs, E349fsLi-Fraumeni syndromeLikely pathogenic
(Aug 9, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr17:7573973
GRCh38:
Chr17:7670655
TP53D220fs, D313fs, D352fs, D193fsLi-Fraumeni syndromeLikely pathogenic
(Oct 14, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr17:7573975
GRCh38:
Chr17:7670657
TP53K192fs, K219fs, K312fs, K351fsLi-Fraumeni syndromeLikely pathogenic
(Aug 3, 2020)
criteria provided, single submitter
17.
GRCh37:
Chr17:7573976
GRCh38:
Chr17:7670658
TP53K192*, K219*, K312*, K351*Lung adenocarcinomaPathogenic
(Jun 6, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr17:7573976-7573984
GRCh38:
Chr17:7670658-7670666
TP53Li-Fraumeni syndromePathogenic
(Feb 4, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr17:7573977-7573978
GRCh38:
Chr17:7670659-7670660
TP53L191fs, L311fs, L350fs, L218fsHereditary cancer-predisposing syndromePathogenic
(Feb 21, 2019)
criteria provided, single submitter
20.
GRCh37:
Chr17:7573982
GRCh38:
Chr17:7670664
TP53E217*, E310*, E349*, E190*Li-Fraumeni syndrome, not providedPathogenic
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr17:7573984
GRCh38:
Chr17:7670666
TP53L189fs, L216fs, L309fs, L348fsLi-Fraumeni syndromeLikely pathogenic
(Feb 3, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr17:7573987
GRCh38:
Chr17:7670669
TP53A215D, A308D, A347D, A188DLi-Fraumeni syndromeLikely pathogenic
(Mar 18, 2022)
reviewed by expert panel
FDA Recognized Database
23.
GRCh37:
Chr17:7573991
GRCh38:
Chr17:7670673
TP53E214*, E307*, E346*, E187*Li-Fraumeni syndromePathogenic
(Aug 26, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr17:7573991
GRCh38:
Chr17:7670673
TP53E187fs, E346fs, E214fs, E307fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
25.
GRCh37:
Chr17:7573993-7574000
GRCh38:
Chr17:7670675-7670682
TP53Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
26.
GRCh37:
Chr17:7573996
GRCh38:
Chr17:7670678
TP53L344P, L212P, L305P, L185PLi-Fraumeni syndromeLikely pathogenic
(Aug 28, 2019)
reviewed by expert panel
FDA Recognized Database
27.
GRCh37:
Chr17:7573999
GRCh38:
Chr17:7670681
TP53E184fs, E211fs, E304fs, E343fsHereditary cancer-predisposing syndrome, Li-Fraumeni syndromePathogenic/Likely pathogenic
(Jun 21, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr17:7573999-7574008
GRCh38:
Chr17:7670681-7670690
TP53M340fs, M181fs, M208fs, M301fsHereditary cancer-predisposing syndromePathogenic
(May 31, 2019)
criteria provided, single submitter
29.
GRCh37:
Chr17:7574002
GRCh38:
Chr17:7670684
TP53R210P, R303P, R342P, R183PHereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1,
Li-Fraumeni syndrome
Pathogenic/Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr17:7574003
GRCh38:
Chr17:7670685
TP53R183fs, R303fs, R342fs, R210fsHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr17:7574003
GRCh38:
Chr17:7670685
TP53R210*, R303*, R342*, R183*Glioma susceptibility 1, Li-Fraumeni syndrome 1, Basal cell carcinoma, susceptibility to, 7,
Adrenocortical carcinoma, hereditary, Bone osteosarcoma, Nasopharyngeal carcinoma,
Carcinoma of pancreas, Hepatocellular carcinoma, Familial cancer of breast,
Colorectal cancer, Choroid plexus papillomaBone marrow failure syndrome 5,
Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1,
Li-Fraumeni syndrome, ...see more
Pathogenic
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr17:7574006
GRCh38:
Chr17:7670688
TP53F209fs, F341fs, F182fs, F302fsLi-Fraumeni syndromePathogenic
(Nov 26, 2019)
criteria provided, single submitter
33.
GRCh37:
Chr17:7574009
GRCh38:
Chr17:7670691
TP53M340fs, M181fs, M208fs, M301fsHereditary cancer-predisposing syndromePathogenic
(Jun 8, 2011)
criteria provided, single submitter
34.
GRCh37:
Chr17:7574012-7574013
GRCh38:
Chr17:7670694-7670695
TP53E180fs, E207fs, E300fs, E339fsLi-Fraumeni syndromePathogenic
(Oct 5, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr17:7574012-7574013
GRCh38:
Chr17:7670694-7670695
TP53E207*, E180*, E300*, E339*Neoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
36.
GRCh37:
Chr17:7574012
GRCh38:
Chr17:7670694
TP53E207*, E300*, E339*, E180*Hereditary cancer-predisposing syndrome, Li-Fraumeni syndromePathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr17:7574016-7574017
GRCh38:
Chr17:7670698-7670699
TP53R298fs, R178fs, R205fs, R337fsHereditary cancer-predisposing syndromePathogenic
(Jul 25, 2016)
criteria provided, single submitter
38.
GRCh37:
Chr17:7574017
GRCh38:
Chr17:7670699
TP53R205P, R298P, R337P, R178PHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr17:7574017
GRCh38:
Chr17:7670699
TP53R205L, R298L, R337L, R178LHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Familial cancer of breast
Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr17:7574017
GRCh38:
Chr17:7670699
TP53R337H, R205H, R298H, R178HGlioma susceptibility 1, Adrenocortical carcinoma, hereditary, Nasopharyngeal carcinoma,
Bone osteosarcoma, Colorectal cancer, Familial cancer of breast,
Bone marrow failure syndrome 5, Hepatocellular carcinoma, Basal cell carcinoma, susceptibility to, 7,
Carcinoma of pancreas, Choroid plexus papillomaLi-Fraumeni syndrome 1,
Breast neoplasm, Hereditary cancer-predisposing syndrome, not provided,
Hereditary breast ovarian cancer syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome,
Squamous cell carcinoma of the head and neck, See cases, ...see more
Pathogenic/Likely pathogenic
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr17:7574018
GRCh38:
Chr17:7670700
TP53R205C, R298C, R337C, R178CHereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1,
Li-Fraumeni syndrome
Pathogenic/Likely pathogenic
(Feb 3, 2023)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr17:7574024-7574055
GRCh38:
Chr17:7670706-7670737
TP53Neoplasm of ovaryLikely pathogenic
(Dec 1, 2018)
no assertion criteria provided
43.
GRCh37:
Chr17:7574027
GRCh38:
Chr17:7670709
TP53G202W, G295W, G334W, G175WHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr17:7574030
GRCh38:
Chr17:7670712
TP53R201fs, R294fs, R333fs, R174fsLi-Fraumeni syndromePathogenic
(Apr 11, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr17:7574030-7574031
GRCh38:
Chr17:7670712-7670713
TP53I293fs, I173fs, I200fs, I332fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
46.
GRCh37:
Chr17:7574032
GRCh38:
Chr17:7670714
TP53I173N, I200N, I293N, I332NHereditary cancer-predisposing syndromeLikely pathogenic
(Feb 4, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr17:7574034
GRCh38:
Chr17:7670716
TP53Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr17:7574034
GRCh38:
Chr17:7670716
TP53Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome,
Li-Fraumeni syndrome 1
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr17:7574035
GRCh38:
Chr17:7670717
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndromePathogenic
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr17:7576851
GRCh38:
Chr17:7673533
TP53Familial cancer of breast, Hereditary cancer-predisposing syndromeLikely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr17:7576852
GRCh38:
Chr17:7673534
TP53Li-Fraumeni syndromePathogenic
(Aug 9, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr17:7576852
GRCh38:
Chr17:7673534
TP53Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome,
Li-Fraumeni syndrome 1
Pathogenic/Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr17:7576852
GRCh38:
Chr17:7673534
TP53Li-Fraumeni syndromePathogenic
(Aug 28, 2019)
reviewed by expert panel
FDA Recognized Database
54.
GRCh37:
Chr17:7576852
GRCh38:
Chr17:7673534
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, not provided,
Li-Fraumeni syndrome 1
Pathogenic/Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr17:7576853-7576854
GRCh38:
Chr17:7673535-7673536
TP53D173fs, D200fs, D293fs, D332fs, I173fs, I200fs, I293fs, I332fs, M173fs, M200fs, M293fs, M332fsLi-Fraumeni syndromeLikely pathogenic
(Aug 26, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr17:7576853-7576856
GRCh38:
Chr17:7673535-7673538
TP53Q331fs, Q199fs, Q172fs, Q292fsLi-Fraumeni syndromePathogenic
(Aug 12, 2021)
criteria provided, single submitter
57.
GRCh37:
Chr17:7576853
GRCh38:
Chr17:7673535
TP53Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome,
not provided
Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr17:7576855
GRCh38:
Chr17:7673537
TP53Q199*, Q331*, Q292*, Q172*Hereditary cancer-predisposing syndromePathogenic
(Mar 2, 2020)
criteria provided, single submitter
59.
GRCh37:
Chr17:7576856
GRCh38:
Chr17:7673538
TP53Q172fs, Q199fs, Q331fs, Q292fsLi-Fraumeni syndromePathogenic
(Jan 30, 2021)
criteria provided, single submitter
60.
GRCh37:
Chr17:7576858
GRCh38:
Chr17:7673540
TP53L198fs, L291fs, L330fs, L171fsHereditary cancer-predisposing syndrome, Li-Fraumeni syndromePathogenic
(Dec 12, 2021)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr17:7576860-7576878
GRCh38:
Chr17:7673542-7673560
TP53L323fs, L164fs, L191fs, L284fsHereditary cancer-predisposing syndromePathogenic
(May 29, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr17:7576862-7576863
GRCh38:
Chr17:7673544-7673545
TP53T197fs, T170fs, T290fs, T329fsLi-Fraumeni syndromePathogenic
(Apr 26, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr17:7576862-7576863
GRCh38:
Chr17:7673544-7673545
TP53T290fs, T329fs, T197fs, T170fsHereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1,
Li-Fraumeni syndrome
Pathogenic
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr17:7576865
GRCh38:
Chr17:7673547
TP53Y168*, Y195*, Y327*, Y288*Li-Fraumeni syndromePathogenic
(May 1, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr17:7576865-7576866
GRCh38:
Chr17:7673547-7673548
TP53Y168fs, Y195fs, Y327fs, Y288fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
66.
GRCh37:
Chr17:7576865
GRCh38:
Chr17:7673547
TP53Y195*, Y288*, Y327*, Y168*not providedLikely pathogenic
(Aug 9, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr17:7576868-7576869
GRCh38:
Chr17:7673550-7673551
TP53Y168fs, Y288fs, Y327fs, Y195fsHereditary cancer-predisposing syndromePathogenic
(Jul 30, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr17:7576870
GRCh38:
Chr17:7673552
TP53E194*, E287*, E326*, E167*Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr17:7576873
GRCh38:
Chr17:7673555
TP53G193*, G286*, G325*, G166*Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, not provided
Pathogenic
(Apr 5, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:7576876
GRCh38:
Chr17:7673558
TP53D165fs, D192fs, D285fs, D324fsnot providedLikely pathogenicno assertion criteria provided
71.
GRCh37:
Chr17:7576881
GRCh38:
Chr17:7673563
TP53P190fs, P163fs, P283fs, P322fsHereditary cancer-predisposing syndromePathogenic
(Oct 13, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr17:7576885
GRCh38:
Chr17:7673567
TP53K189*, K282*, K162*, K321*Li-Fraumeni syndromePathogenic
(May 25, 2019)
criteria provided, single submitter
73.
GRCh37:
Chr17:7576888
GRCh38:
Chr17:7673570
TP53K161*, K188*, K281*, K320*Li-Fraumeni syndrome, Hereditary cancer-predisposing syndromePathogenic
(Dec 16, 2020)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr17:7576892-7576895
GRCh38:
Chr17:7673574-7673577
TP53P159fs, P186fs, P279fs, P318fsHereditary cancer-predisposing syndromePathogenic
(Nov 14, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr17:7576896
GRCh38:
Chr17:7673578
TP53Q158fs, Q317fs, Q185fs, Q278fsHereditary cancer-predisposing syndromePathogenic
(Jul 14, 2016)
criteria provided, single submitter
76.
GRCh37:
Chr17:7576897
GRCh38:
Chr17:7673579
TP53Q185fs, Q278fs, Q158fs, Q317fsLi-Fraumeni syndromePathogenic
(Jan 16, 2020)
criteria provided, single submitter
77.
GRCh37:
Chr17:7576897
GRCh38:
Chr17:7673579
TP53Q185*, Q278*, Q317*, Q158*Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, not provided,
Li-Fraumeni syndrome 1
Pathogenic/Likely pathogenic
(Mar 15, 2023)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr17:7576900-7576901
GRCh38:
Chr17:7673582-7673583
TP53P157fs, P316fs, P184fs, P277fsLi-Fraumeni syndromePathogenic
(Feb 12, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr17:7576900-7576901
GRCh38:
Chr17:7673582-7673583
TP53Q278fs, Q185fs, Q317fs, Q158fsLi-Fraumeni syndromePathogenic
(Dec 23, 2020)
criteria provided, single submitter
80.
GRCh37:
Chr17:7576900-7576909
GRCh38:
Chr17:7673582-7673591
TP53S181fs, S274fs, S154fs, S313fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
81.
GRCh37:
Chr17:7576901
GRCh38:
Chr17:7673583
TP53Q158fs, Q185fs, Q278fs, Q317fsLi-Fraumeni syndromePathogenic
(Oct 23, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr17:7576913-7576914
GRCh38:
Chr17:7673595-7673596
TP53N311fs, N179fs, N152fs, N272fsHereditary cancer-predisposing syndromePathogenic
(Mar 20, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr17:7576913
GRCh38:
Chr17:7673595
TP53N179fs, N311fs, N152fs, N272fsNeoplasm of ovaryPathogenic
(Dec 1, 2018)
no assertion criteria provided
84.
GRCh37:
Chr17:7576919
GRCh38:
Chr17:7673601
TP53N178fs, N310fs, N271fs, N151fsnot providedPathogenic
(May 1, 2019)
criteria provided, single submitter
85.
GRCh37:
Chr17:7576923-7576929
GRCh38:
Chr17:7673605-7673611
TP53Li-Fraumeni syndromeLikely pathogenic
(Sep 6, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr17:7576926-7576930
GRCh38:
Chr17:7673608-7673612
TP53Li-Fraumeni syndromeLikely pathogenic
(Oct 14, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr17:7576927
GRCh38:
Chr17:7673609
TP53Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr17:7576927
GRCh38:
Chr17:7673609
TP53Li-Fraumeni syndromePathogenic
(Oct 28, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr17:7576927
GRCh38:
Chr17:7673609
TP53Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome 1,
Li-Fraumeni syndrome
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr17:7576928
GRCh38:
Chr17:7673610
TP53Breast and/or ovarian cancer, Hereditary cancer-predisposing syndrome, not provided,
Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Pathogenic/Likely pathogenic
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr17:7577004-7577021
GRCh38:
Chr17:7673686-7673703
TP53Li-Fraumeni syndromePathogenic
(Aug 12, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr17:7577009-7577021
GRCh38:
Chr17:7673691-7673703
TP53Li-Fraumeni syndrome, Hereditary cancer-predisposing syndromePathogenic/Likely pathogenic
(Aug 12, 2021)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr17:7577013-7577021
GRCh38:
Chr17:7673695-7673703
TP53Li-Fraumeni syndromePathogenic
(Jan 27, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr17:7577017
GRCh38:
Chr17:7673699
TP53Hereditary breast ovarian cancer syndromePathogenic
(May 21, 2019)
no assertion criteria provided
95.
GRCh37:
Chr17:7577017
GRCh38:
Chr17:7673699
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr17:7577018
GRCh38:
Chr17:7673700
TP53Li-Fraumeni syndromePathogenic
(Sep 2, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr17:7577018-7577019
GRCh38:
Chr17:7673700-7673701
TP53Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr17:7577018
GRCh38:
Chr17:7673700
TP53Li-Fraumeni syndromeLikely pathogenic
(Aug 28, 2019)
reviewed by expert panel
FDA Recognized Database
99.
GRCh37:
Chr17:7577018
GRCh38:
Chr17:7673700
TP53Colorectal cancerLikely pathogenic
(Jul 11, 2016)
no assertion criteria provided
100.
GRCh37:
Chr17:7577018
GRCh38:
Chr17:7673700
TP53Hereditary cancer-predisposing syndromeLikely pathogenic
(Apr 11, 2016)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination